Abdul Rafeh Naqash (Abdul R Naqash)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Peripheral Blood

Small Cell Lung Cancer

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Acta oncologica (Stockholm, Sweden)

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Amin H Nassar, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingjia Li, Arjun Mittra, Dwight H Owen, Robert A Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G Lechner, Alexandra Drakaki, Javier Baena, Caroline A Nebhan, Tarek Haykal, Michael A Morse, Alessio Cortellini, David James Pinato, Alessia Dalla Pria, Evan Thomas Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal S Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Ryan W Dobbs, Pauline Funchain, Rabia Saleem, Rachel G Woodford, Georgina V Long, Alexander M Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G Reid, Elizabeth Yu Chiao, Elad Sharon, Douglas B Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U Marron, Toni K Choueiri, Lindsey R Baden, Kathryn Lurain, Guru P Sonpavde, Abdul Rafeh Naqash
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Amin H Nassar, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingjia Li, Arjun Mittra, Dwight H Owen, Robert A Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G Lechner, Alexandra Drakaki, Javier Baena, Caroline A Nebhan, Tarek Haykal, Michael A Morse, Alessio Cortellini, David James Pinato, Alessia Dalla Pria, Evan Thomas Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal S Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Ryan W Dobbs, Pauline Funchain, Rabia Saleem, Rachel G Woodford, Georgina V Long, Alexander M Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G Reid, Elizabeth Yu Chiao, Elad Sharon, Douglas B Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U Marron, Toni K Choueiri, Lindsey R Baden, Kathryn Lurain, Guru P Sonpavde, Abdul Rafeh Naqash
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Brett Marinelli, Edward Kim, Antonio D'Alessio, Mario Cedillo, Ishan Sinha, Neha Debnath, Masatoshi Kudo, Naoshi Nishida, Anwaar Saeed, Hannah Hildebrand, Ahmed O Kaseb, Yehia I Abugabal, Anjana Pillai, Yi-Hsiang Huang, Uqba Khan, Mahvish Muzaffar, Abdul Rafeh Naqash, Rahul Patel, Aaron Fischman, Vivian Bishay, Dominik Bettinger, Max Sung, Celina Ang, Myron Schwartz, David James Pinato, Thomas Marron
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study. Journal for immunotherapy of cancer 10 (6) (2022)
Abdul Rafeh Naqash, Melissa Y Y Moey, Xiao-Wei Cherie Tan, Mehak Laharwal, Vanessa Hill, Nagabhishek Moka, Shanda R Finnigan, James Murray, Douglas B Johnson, Javid J Moslehi, Elad Sharon
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Abdul Rafeh Naqash, Douglas B Johnson, Javid J Moslehi, Elad Sharon
Reply to S. Rossi et al and P. Palassin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Julia Judd, Nagla Abdel Karim, Hina Khan, Abdul Rafeh Naqash, Yasmine Baca, Joanne Xiu, Ari M VanderWalde, Hirva Mamdani, Luis E Raez, Misako Nagasaka, Sachin Gopalkrishna Pai, Mark A Socinski, Jorge J Nieva, Chul Kim, Antoinette J Wozniak, Chukwuemeka Ikpeazu, Gilberto de Lima Lopes, Alexander I Spira, Wolfgang Michael Korn, Edward S Kim, Stephen V Liu, Hossein Borghaei
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer. Molecular cancer therapeutics 20 (12) (2021)
Naoko Takebe, Abdul Rafeh Naqash, Geraldine O'Sullivan Coyne, Shivaani Kummar, Khanh Do, Ashley Bruns, Lamin Juwara, Jennifer Zlott, Lawrence V Rubinstein, Richard L Piekarz, Elad Sharon, Howard Streicher, Arjun Mittra, Sarah B Miller, Jiuping Ji, Deborah Wilsker, Robert J Kinders, Ralph E Parchment, Li Chen, Ting-Chia Chang, Biswasjit Das, Ganesh Mugundu, James H Doroshow, Helen X Chen
Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Arjun Mittra, Abdul Rafeh Naqash, James H Murray, Shanda R Finnigan, Joanne Kwak-Kim, Susan Percy Ivy, Helen X Chen, Elad Sharon
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute. The oncologist 26 (10) (2021)
Abdul Rafeh Naqash, Danielle M File, Carolyn M Ziemer, Young E Whang, Paula Landman, Paul B Googe, Frances A Collichio
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series. Journal for immunotherapy of cancer 7 (1) (2019)
Abdul Rafeh Naqash, Ebenezer Appah, Li V Yang, Mahvish Muzaffar, Mona A Marie, Justin D Mccallen, Shravanti Macherla, Darla Liles, Paul R Walker
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition. Journal for immunotherapy of cancer 7 (1) (2019)
Abdul Rafeh Naqash, Geoffrey Stroud, Frances A Collichio, Mahvish Muzaffar, Nitika Sharma, Paul Walker
Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab. Acta oncologica (Stockholm, Sweden) 56 (10) (2017)
Abdul Rafeh Naqash, Chipman Robert Geoffrey Stroud, Muhammad Umer Butt, Grace K Dy, Aparna Hegde, Mahvish Muzaffar, Li V Yang, Maida Hafiz, Cynthia R Cherry, Paul R Walker
Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database. Acta oncologica (Stockholm, Sweden) 57 (6) (2017)
Abdul Rafeh Naqash, Li V Yang, Edward J Sanderlin, Druid C Atwell, Paul R Walker
Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report. Acta oncologica (Stockholm, Sweden) 57 (5) (2017)
Abdul Rafeh Naqash, Meera Yogarajah, Bethany Dawn Vallangeon, Maida Hafiz, Deval Patel, Evelina Kolychev, Dora Alexandra Lebron, Darla Liles
Hemophagocytic lymphohistiocytosis (HLH) secondary to Ehrlichia chaffeensis with bone marrow involvement. Annals of hematology 96 (10) (2017)